Skip To Main Content
Ftopra Insead on Muck Rack

Ftopra Insead

As seen in: Clinical Leader
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ftopra

Contact Ftopra, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

03.07.24 -- Strategies For Seeking Multiregional Regulatory Approval

|
By Peter Embley, Ftopra Insead, John R. Nocero, Dip. Reg. Aff
| Clinical Leader Verified
Strategies For Seeking Multiregional Regulatory Approval Consultant Peter Embley discusses the importance of developing a regulatory strategy (RS) that intends to support both U.S. and EU regulatory approval. Accelerated Clinical Trial Disclosure Starts Here See why TrialScope Disclose is trusted by 16 of the top 20 industry clinical trial sponsors for optimizing, streamlining, and simplifying the clinical trial disclosure process from registration to results.
Open in Who Shared Issue with article?

Strategies For Seeking Multiregional Regulatory Approval

|
By Peter Embley, Ftopra Insead
| Clinical Leader Verified
Guest Column | February 12, 2024 By Peter Embley, BSc. (Hons), Dip.Reg.Aff, FTOPRA INSEAD Emerging biotech and biopharma companies spend precious time and money on discovering and rapidly building scientific evidence to support the safety and efficacy of their compounds. Such resources are somewhat limited and focused on near-term activities. In doing so, they are often unaware of or undervalue the importance of getting early regulatory guidance on long-range development strategies.
Open in Who Shared Issue with article?
See all 2 articles